Frazier Life Sciences Management’s Attovia Therapeutics ATTO Stock Holding History
Bought
Maintained
Sold
Other funds holding ATTO
Frazier Life Sciences Management's ATTO Position: Q3 2026 in Review
Frazier Life Sciences Management opened a new position in Attovia Therapeutics (ATTO) in Q3 2026: 7,046,271 shares worth $121M. The stake represents 3% of the portfolio and ranks #10 among its holdings.
57 funds tracked by Wall St. Rank hold ATTO as of Q3 2026.
- Frazier Life Sciences Management held 7,046,271 shares of Attovia Therapeutics worth $121M as of Q3 2026.
- Attovia Therapeutics was a new Frazier Life Sciences Management position in Q3 2026.
- Attovia Therapeutics made up 3% of Frazier Life Sciences Management's portfolio in Q3 2026, its #10 holding.
- 57 funds tracked by Wall St. Rank held Attovia Therapeutics as of Q3 2026.
Based on Frazier Life Sciences Management's 13F filing for Q3 2026, filed 16 Nov 2026.